These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9198210)

  • 1. Vitamin K-dependent protein production in transgenic animals.
    Luboń H; Paleyanda RK
    Thromb Haemost; 1997 Jul; 78(1):532-6. PubMed ID: 9198210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional recombinant human factor IX in milk of mice.
    Lisauskas SF; Cunha NB; Vianna GR; Mendes EA; Ramos GL; Maranhão AQ; Brígido MM; Almeida JO; Baptista HA; Motta FL; Pesquero JB; Aragão FJ; Rech EL
    Biotechnol Lett; 2008 Dec; 30(12):2063-9. PubMed ID: 18688573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of the human gamma-carboxylase and a gamma-carboxylase-associated protein from factor IX-expressing mammalian cells.
    Lingenfelter SE; Berkner KL
    Biochemistry; 1996 Jun; 35(25):8234-43. PubMed ID: 8679578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of therapeutic proteins in the milk of transgenic livestock.
    Colman A
    Biochem Soc Symp; 1998; 63():141-7. PubMed ID: 9513718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control of protein C: protein C synthesized in the presence of warfarin is selectively degraded in the endoplasmic reticulum.
    Koide T; Tokunaga F; Wakabayashi S
    Pol J Pharmacol; 1996; 48(2):203-7. PubMed ID: 9112652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro carboxylation of a blood coagulation factor IX precursor produced by recombinant-DNA technology.
    Soute BA; Balland A; Faure T; de la Salle H; Vermeer C
    Thromb Haemost; 1989 Apr; 61(2):238-42. PubMed ID: 2749597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The past, present and future of transgenic bioreactors.
    Drohan WN
    Thromb Haemost; 1997 Jul; 78(1):543-7. PubMed ID: 9198212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX.
    Blostein M; Cuerquis J; Landry S; Galipeau J
    Haemophilia; 2008 Sep; 14(5):1063-8. PubMed ID: 18680528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot production of recombinant human clotting factor IX from transgenic sow milk.
    Sun YL; Chang YS; Lin YS; Yen CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():78-89. PubMed ID: 22578515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of bioproducts through the use of transgenic animal models.
    Keefer CL
    Anim Reprod Sci; 2004 Jul; 82-83():5-12. PubMed ID: 15271439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant plasma proteins.
    Burnouf T
    Vox Sang; 2011 Jan; 100(1):68-83. PubMed ID: 21175657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current progress in the production of recombinant human fibrinogen in the milk of transgenic animals.
    Butler SP; van Cott K; Subrumanian A; Gwazduaskas FC; Velander WH
    Thromb Haemost; 1997 Jul; 78(1):537-42. PubMed ID: 9198211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.
    Berkner KL
    Methods Enzymol; 1993; 222():450-77. PubMed ID: 8412810
    [No Abstract]   [Full Text] [Related]  

  • 16. Transgenic pigs produce functional human factor VIII in milk.
    Paleyanda RK; Velander WH; Lee TK; Scandella DH; Gwazdauskas FC; Knight JW; Hoyer LW; Drohan WN; Lubon H
    Nat Biotechnol; 1997 Oct; 15(10):971-5. PubMed ID: 9335047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of functional recombinant bovine follicle-stimulating hormone (boFSHalpha/beta) produced in the milk of transgenic rabbits.
    Coulibaly S; Besenfelder U; Miller I; Zinovieva N; Lassnig C; Kotler T; Jameson JL; Gemeiner M; Müller M; Brem G
    Mol Reprod Dev; 2002 Nov; 63(3):300-8. PubMed ID: 12237945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three in-frame ATG, clustered in the translation initiation sequence of human factor IX gene, are required for an optimal protein production.
    Enjolras N; Rodriguez MH; Plantier JL; Maurice M; Attali O; Négrier C
    Thromb Haemost; 1999 Oct; 82(4):1264-9. PubMed ID: 10544911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of mammary gland-specific expression vectors for human clotting factor IX and its secretory expression in goat milk.
    Zhang K; Lu D; Xue J; Huang Y; Huang S
    Chin J Biotechnol; 1997; 13(4):271-6. PubMed ID: 9631263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A galactopoiesis accordant yield of functional recombinant human factor IX from homozygous transgenic pigs requires a large amount of vitamin K supplementation.
    Yen CH; Yang TS; Lin YS; Lee MH; Yu KC; Huang CL; Hsieh HH; Tu CF
    Transgenic Res; 2016 Aug; 25(4):545-51. PubMed ID: 27160182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.